EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation

Matthew D Ettleson iD, Kelly Karavolos, Sherri-Ann M Burnett-Bowie, Lynda H Powell, Imke Janssen

Thyroid® · 2024

DOI: 10.1089/thy.2024.0358 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Thyroid®, 2024. Verfasst von Matthew D Ettleson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Hypothyroidism, Menopause, Cognition, Thyroxine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients treated for hypothyroidism with levothyroxine (LT4) monotherapy may present with persistent hypothyroidism symptoms, including cognitive symptoms, despite having a normal thyroid stimulating hormone (TSH) level. It remains unclear whether LT4 monotherapy is sufficient to normalize cognitive function outcomes over time.

Methods

This is a multisite longitudinal study of a diverse group of women during midlife representing 5 ethnic/racial groups from 7 enrollment sites across the United States in the Study of Women’s Health Across the Nation. Women were screened for a history of thyroid disease and the use of LT4. The study consisted of two primary groups: women with LT4-treated hypothyroidism and control women without thyroid disease. Each participant completed up to 9 cognitive assessments over the study period testing processing speed, working memory, and episodic memory (immediate and delayed recall). Multivariable generalized linear mixed models of scores for each cognitive assessment were developed to determine the association between LT4-treated hypothyroidism and cognitive function trajectories. Covariates included sociodemographic, clinical characteristics, and menopausal status (pre/early peri, late peri, and surgical/post). Sensitivity analyses were conducted to assess the impact of abnormal TSH levels and practice effects (i.e., improvements in scoring after repeated testing).

Results

Of the 2033 women who were included in the study, 227 (11.2%) met criteria for LT4-treated hypothyroidism. At baseline, both processing speed and working memory scores were higher in LT4-treated women (mean processing speed scores: 56.5 vs 54.4; p value = 0.006; mean working memory scores: 6.8 vs 6.4; p value = 0.018). However, when considering the effect of LT4-treated hypothyroidism over time, there were no significant differences in the rate of cognitive decline (in any measure) between the hypothyroidism and control groups with or without covariate adjustment. The results were similar when considering LT4-treated women with abnormal TSH levels or after minimizing practice effects.

Conclusions

We observed no difference in cognitive decline between women with LT4-treated hypothyroidism and women without thyroid disease. For similar aged patients with cognitive complaints, if thyroid function testing is normal, clinicians should consider causes other than inadequate thyroid hormone treatment to explain these symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismMenopauseCognitionThyroxineWomen's HealthThyrotropinHumansFemaleMiddle AgedLongitudinal StudiesUnited StatesAdultCognitive Dysfunction

Stichwörter der Autor:innen

cognitive functionhypothyroidismlevothyroxinemenopause

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, Illinois, USA.
  • Department of Family & Preventative Medicine, Rush University Medical Centers, Chicago, Illinois, USA.
  • Endocrine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, USA.

ORCID-Profile: Matthew D Ettleson

Förderung

  • NIA NIH HHS
  • NINR NIH HHS

Zitieren

APA

Ettleson, M. D., Karavolos, K., Burnett-Bowie, S. M., Powell, L. H., & Janssen, I. (2024). The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation. Thyroid®. https://doi.org/10.1089/thy.2024.0358

Vancouver

Ettleson MD, Karavolos K, Burnett-Bowie SM, Powell LH, Janssen I. The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation. Thyroid®. 2024. doi:10.1089/thy.2024.0358

BibTeX
@article{Ettleson2024,
  author = {Ettleson, Matthew D and Karavolos, Kelly and Burnett-Bowie, Sherri-Ann M and Powell, Lynda H and Janssen, Imke},
  title = {The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation},
  journal = {Thyroid®},
  year = {2024},
  doi = {10.1089/thy.2024.0358}
}
Kostenlos starten →